Form 4: Evolent Health Director Toyin Ajayi Receives Stock Grant

Director Toyin Ajayi received 7,709 shares of Evolent Health Class A Common Stock as restricted stock units on June 6, 2024.

Summary

• On June 6, 2024, Toyin Ajayi, a director of Evolent Health, Inc., acquired 7,709 shares of Class A Common Stock.
• These shares were granted as restricted stock units under the company's 2015 Omnibus Incentive Compensation Plan.
• The restricted stock units vest on the earlier of June 6, 2025, or the date of the company's 2025 annual meeting, contingent upon continued service.
• Following the transaction, Ajayi directly owns 12,095 shares of Evolent Health's Class A Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (stock grant) which is generally viewed positively as it aligns director interests with shareholders. There are no indications of negative sentiment.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the restricted stock units.

Industry Context

This type of stock grant is a common practice in publicly traded companies to incentivize and retain key personnel such as directors.

Comparison to Industry Standards

• Stock grants to directors are a standard component of compensation packages in publicly traded companies, aligning their interests with shareholders.
• Companies like UnitedHealth Group (UNH) and Humana (HUM) also utilize stock grants as part of their director compensation packages.
• The vesting schedule of one year is fairly standard, similar to practices observed at other healthcare companies such as CVS Health (CVS).

Stakeholder Impact

• The stock grant aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term value.
• The vesting schedule incentivizes the director to remain with the company, providing stability and experience.

Key Dates